Casdin Capital’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,150,000
| Closed | -$6.41M | – | 45 |
|
|
2024
Q4 | $6.41M | Hold |
1,150,000
| – | – | 0.43% | 25 |
|
|
2024
Q3 | $12.4M | Buy |
1,150,000
+350,000
| +44% | +$3.78M | 0.83% | 21 |
|
|
2024
Q2 | $16.8M | Hold |
800,000
| – | – | 1.28% | 18 |
|
|
2024
Q1 | $25.5M | Sell |
800,000
-233,811
| -23% | -$7.45M | 1.89% | 18 |
|
|
2023
Q4 | $20.9M | Hold |
1,033,811
| – | – | 2.06% | 15 |
|
|
2023
Q3 | $13.2M | Sell |
1,033,811
-36,189
| -3% | -$461K | 1.46% | 19 |
|
|
2023
Q2 | $19.3M | Hold |
1,070,000
| – | – | 1.69% | 20 |
|
|
2023
Q1 | $18.4M | Buy |
1,070,000
+440,000
| +70% | +$7.56M | 1.52% | 20 |
|
|
2022
Q4 | $14M | Buy |
+630,000
| New | +$14M | 1.08% | 26 |
|
|
2022
Q3 | – | Sell |
-555,455
| Closed | -$3.88M | – | 38 |
|
|
2022
Q2 | $3.88M | Hold |
555,455
| – | – | 0.33% | 33 |
|
|
2022
Q1 | $8.4M | Hold |
555,455
| – | – | 0.38% | 39 |
|
|
2021
Q4 | $12.2M | Sell |
555,455
-560,000
| -50% | -$12.3M | 0.34% | 42 |
|
|
2021
Q3 | $30.1M | Sell |
1,115,455
-100
| -0% | -$2.7K | 0.75% | 34 |
|
|
2021
Q2 | $26.9M | Buy |
1,115,555
+120,201
| +12% | +$2.89M | 0.68% | 33 |
|
|
2021
Q1 | $43.2M | Buy |
995,354
+214,799
| +28% | +$9.32M | 1.29% | 21 |
|
|
2020
Q4 | $32.4M | Buy |
+780,555
| New | +$32.4M | 0.96% | 27 |
|